drugset / Trial / NCT05150392
An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This is an open-labelled clinical trial of live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd .The purpose of this study is to evaluate the immunity persistence of the single-dose primary immunization of live attenuated varicella vaccine on different time points ,and the safety and immunogenicity after the booster immunization
Timeline
- Start
- 2018-07-11
- Primary completion
- 2018-08-11
- Completion
- 2020-08-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Investigational live attenuated varicella vaccine | Vaccine | 0.5 ml | — |